Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2019
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Pulmonary embolism
- Focus Diagnostic use
- 20 Jan 2019 Status changed from not yet recruiting to recruiting.
- 23 Aug 2018 Planned initiation date changed from 1 Aug 2018 to 1 Sep 2018.
- 20 Jul 2018 Protocol has been amended to change the trial phase from I/II to Phase III